However, apart of the pneumonitis, it was hypothesized that TGF-β appears to be produced either directly or indirectly by some NSCLC, and declining plasma levels during therapy may be indicative of tumor cell death (17). The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.